We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Hims & Hers Expands Platform-Led Access to Digital Healthcare
Read MoreHide Full Article
Key Takeaways
Hims & Hers scales digital care using a unified, data-driven platform that improves with every interaction.
HIMS adds weight loss and menopause care without rebuilding its core digital infrastructure.
Hims & Hers expands into labs, AI and new markets using the same scalable software and data infrastructure.
The renowned health and wellness platform, Hims & Hers Health, Inc. (HIMS - Free Report) , built its growth strategy around a highly scalable, software-driven platform that becomes more powerful as usage expands. The company’s digital infrastructure connects consumers, licensed providers, fulfillment and diagnostics into a single system, allowing each interaction to improve personalization and efficiency. Management emphasizes that scale does not simply add volume; it strengthens data feedback loops that refine treatment recommendations, improve retention and support a growing mix of multi-condition and proactive care. This platform-centric approach has supported rapid subscriber growth while maintaining operating leverage, as technology and development investments increasingly translate into broader reach and deeper engagement.
Recent launches underscore how software and data enable expansion across new categories without rebuilding the core operating model. Weight loss, alongside low testosterone, menopause and perimenopause, and upcoming whole-body lab testing, is delivered through a unified digital workflow that combines at-home testing, ongoing provider support, and data-driven personalization. The planned rollout of comprehensive lab testing and the longevity specialty further extends this model, positioning data as the entry point for proactive and preventive health management rather than episodic treatment.
At the same time, Hims & Hers is reinforcing its platform with targeted investments in AI, data pipelines and vertically integrated infrastructure. Capital raised in 2025 is earmarked to deepen these capabilities, while international expansion into Europe and Canada leverages the same software backbone. Together, these developments highlight a strategy where scalable technology and data — not physical footprint — remain the primary engines of growth.
TDOC & AMWL’s Platform-Led Scaling of Virtual Care
Teladoc Health, Inc. (TDOC - Free Report) continues to emphasize scalability by anchoring growth in software, data integration and platform breadth. Teladoc Health positions its Prism care delivery platform as the backbone that unifies clinical workflows, real-time data and provider collaboration at scale. Recent enhancements to TDOC’s 24/7 Care expand the range of treatable conditions while leveraging integrated claims and health data to drive preventive action. Teladoc Health is further extending this model through AI-enabled Clarity monitoring, reinforcing how data-driven infrastructure supports scalable, system-wide virtual care.
American Well Corporation (AMWL - Free Report) , popularly known as Amwell, centers its scalability strategy on the Amwell Converge platform, designed as a single, cloud-based operating system for hybrid care. Amwell enables clients to activate new use cases — ranging from virtual nursing to automated care — on the same data architecture without incremental complexity. AMWL’s continued rollout of Converge across large enterprises, including its expanded work with the U.S. Defense Health Agency, highlights how Amwell scales efficiently through standardized software, embedded analytics, and an increasingly AI-powered platform that grows alongside client demand.
HIMS’ Price Performance, Valuation and Estimates
Shares of Hims & Hers have gained 12.7% over the past year, outperforming the industry’s decline of 2.7%.
Image Source: Zacks Investment Research
HIMS’ forward 12-month P/S of 2.6X is lower than the industry’s average of 4.7X and its three-year median of 2.7X. It carries a Value Score of C.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for HIMS’ 2025 earnings per share suggests a 77.8% improvement from 2024.
Image Source: Zacks Investment Research
Hims & Hers currently carries a Zacks Rank #4 (Sell).
Image: Bigstock
Hims & Hers Expands Platform-Led Access to Digital Healthcare
Key Takeaways
The renowned health and wellness platform, Hims & Hers Health, Inc. (HIMS - Free Report) , built its growth strategy around a highly scalable, software-driven platform that becomes more powerful as usage expands. The company’s digital infrastructure connects consumers, licensed providers, fulfillment and diagnostics into a single system, allowing each interaction to improve personalization and efficiency. Management emphasizes that scale does not simply add volume; it strengthens data feedback loops that refine treatment recommendations, improve retention and support a growing mix of multi-condition and proactive care. This platform-centric approach has supported rapid subscriber growth while maintaining operating leverage, as technology and development investments increasingly translate into broader reach and deeper engagement.
Recent launches underscore how software and data enable expansion across new categories without rebuilding the core operating model. Weight loss, alongside low testosterone, menopause and perimenopause, and upcoming whole-body lab testing, is delivered through a unified digital workflow that combines at-home testing, ongoing provider support, and data-driven personalization. The planned rollout of comprehensive lab testing and the longevity specialty further extends this model, positioning data as the entry point for proactive and preventive health management rather than episodic treatment.
At the same time, Hims & Hers is reinforcing its platform with targeted investments in AI, data pipelines and vertically integrated infrastructure. Capital raised in 2025 is earmarked to deepen these capabilities, while international expansion into Europe and Canada leverages the same software backbone. Together, these developments highlight a strategy where scalable technology and data — not physical footprint — remain the primary engines of growth.
TDOC & AMWL’s Platform-Led Scaling of Virtual Care
Teladoc Health, Inc. (TDOC - Free Report) continues to emphasize scalability by anchoring growth in software, data integration and platform breadth. Teladoc Health positions its Prism care delivery platform as the backbone that unifies clinical workflows, real-time data and provider collaboration at scale. Recent enhancements to TDOC’s 24/7 Care expand the range of treatable conditions while leveraging integrated claims and health data to drive preventive action. Teladoc Health is further extending this model through AI-enabled Clarity monitoring, reinforcing how data-driven infrastructure supports scalable, system-wide virtual care.
American Well Corporation (AMWL - Free Report) , popularly known as Amwell, centers its scalability strategy on the Amwell Converge platform, designed as a single, cloud-based operating system for hybrid care. Amwell enables clients to activate new use cases — ranging from virtual nursing to automated care — on the same data architecture without incremental complexity. AMWL’s continued rollout of Converge across large enterprises, including its expanded work with the U.S. Defense Health Agency, highlights how Amwell scales efficiently through standardized software, embedded analytics, and an increasingly AI-powered platform that grows alongside client demand.
HIMS’ Price Performance, Valuation and Estimates
Shares of Hims & Hers have gained 12.7% over the past year, outperforming the industry’s decline of 2.7%.
Image Source: Zacks Investment Research
HIMS’ forward 12-month P/S of 2.6X is lower than the industry’s average of 4.7X and its three-year median of 2.7X. It carries a Value Score of C.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for HIMS’ 2025 earnings per share suggests a 77.8% improvement from 2024.
Image Source: Zacks Investment Research
Hims & Hers currently carries a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.